Lidothol Es System
Product Images NDC 83881-445

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidothol Es (NDC 83881-445). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine (Asset 1)

Chemical structure diagram showing the molecular formula of lidocaine, an active ingredient in the drug product Lidothol ES. The structure displays a benzene ring with various attached groups including amide and ethyl substituents.*

FDA Label Image

Menthol (Asset 2)

Chemical structure diagram showing the molecular structure of menthol, an active ingredient in Lidothol ES. The diagram depicts a cyclohexane ring with methyl and hydroxyl groups attached.*

FDA Label Image

Figure1 (Asset 3)

A line graph depicting plasma lidocaine concentration (ng/mL) measured over 72 hours. The graph shows cyclical peaks and troughs in lidocaine levels roughly every 24 hours, with values ranging approximately from near 0 to above 120 ng/mL. The x-axis represents time in hours, and the y-axis represents plasma lidocaine concentration.*

FDA Label Image

Figure2 (Asset 4)

An illustration titled 'Proposed metabolic pathway of menthol' showing the chemical structures and transformations of menthol and its metabolites, including para-Menthane-3,7-diol, para-Menthane-3,9-diol, para-Menthane-3,8-diol, Menthol-9-carboxylic acid, and 3,8-Dihydro-para-menthane-7-carboxylic acid, connected by arrows indicating metabolic steps and pathways such as enterohepatic circulation and excretion via urine and feces.*

FDA Label Image

Logo (Clinicpharma)

FDA Label Image

Lidothol Es Carton Back (Lidothol Es Carton Back 011426)

Drug information for Lidothol ES transdermal system with active ingredients menthol 5% and lidocaine 4%. The panel includes sections on use, warnings, directions for adults 18 years and older, other information, inactive ingredients, and contact for questions. It also features visual instructions for opening and applying the product, includes a barcode, and states it is manufactured by Clinic Pharma in the USA.*

FDA Label Image

Lidothol Es Carton Front (Lidothol Es Carton Front 011426)

Packaging label for Lidothol ES, a transdermal system containing lidocaine 4% and menthol 5% in a drug-in-adhesive formulation. The label indicates it is an Rx-only product by Clinic Pharma, with a package size of 15 systems measuring 10 cm x 14 cm (3.9 in x 5.5 in). Features highlighted include extra strength, water resistance, all-night hold, and suitability for active wear.*

FDA Label Image

Di Table (Di Table)

A table listing categories of drugs with corresponding examples. Categories include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, each paired with specific example drugs in the list.*

FDA Label Image

Table1 (Table1)

A data table titled 'Absorption of Lidocaine from Lidocaine 5% Patch' showing results for 15 normal volunteers wearing patches for 12 hours. The table presents the application site (back), area covered (420 cm²), dose absorbed (64 ± 32 mg), plasma concentration (0.13 ± 0.06 µg/mL), and time (11 hours) for 3 patches delivering 2100 mg total.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.